Additionally, semaglutide GLP-1 has been shown to slow down gastric emptying, leading to increased feelings of fullness and potentially altering nutrient absorption and digestion
It may take a few months to over a year to show significant improvements in body weight and blood sugar control
Similarly, other subgroup analyses have explored the role of baseline cardiovascular risk as a potential effect modifier regarding the effect of treatment on MACE, HHF or kidney outcomes
Remember, managing side effects is a crucial step in maintaining your treatment plan and achieving better health outcomes
www.bluehealthintelligence.com
Medications like methylphenidate, which primarily target dopamine and norepinephrine, are effective in improving symptoms in around 60-70% of patients